Frequency of Gabapentin in Post Mortem cases screened by Enzyme Linked Immunosorbent Assay (ELISA)

Authors

Denice M. Teem, BS
Daniel S. Isenschmid, Ph.D

Impact statement

This presentation impacts the forensic science community by providing frequency, concentrations and drug co-administration information of Gabapentin in post mortem cases submitted to our laboratory. This data will provide laboratories information to help make decisions as to whether or not they should include Gabapentin as part of their own testing regimen.

Request a Copy

Request a PDF copy of the poster by completing the information below.

First Name

Last Name

Organization

City/Town

State/Province

What code is in the image? Enter the characters shown in the image.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.